Evicita · Supplement evidence, graded and cited · Supplements · Lifestyle · Mechanisms · Lab tests · 中文

Gliadin-encapsulated superoxide dismutase (GliSODin)

GliSODin Melon SOD (Melon Extract + Gliadin) · also known as GliSODin, Melon SOD, Gliadin-encapsulated SOD, Antioxidant enzyme

GliSODin is a melon extract with SOD activity, coated in gliadin. In one human trial in athletes, red blood cell SOD activity rose after supplementation. However, Nrf2-related markers were not measured, and the study could not separate enzyme supplied by the supplement from the body’s own enzyme.

Typical dose: Standard GliSODin (labeled at 500–1000 IU of SOD activity): 250–500 mg/day, taken on an empty stomach in the morning. The conversion between mg and SOD activity units depends on each product’s testing method, so follow the label of the specific product.
Absorption and forms: Oral SOD protein is affected by the digestive environment of the stomach. There is no reliable evidence that unencapsulated SOD is fully inactivated in the stomach, and no evidence that this formulation lets intact enzyme pass from the gut into the blood.

Clinical uses and human evidence

Fatigue and energy

Mixed resultsGrade C · Preliminary evidence
Studies (2)
  1. Houghton 2011 · Phytomedicine · RCT · n=38 — Effects of a gliadin-combined plant superoxide dismutase extract on self-perceived fatigue in women aged 50-65 years
  2. Carillon 2014 · Nutrients · RCT · n=61 — Dietary supplementation with a superoxide dismutase-melon concentrate reduces stress, physical and mental fatigue in healthy people: a randomised, double-blind, placebo-controlled trial

Anxiety and stress

Mixed resultsGrade C · Preliminary evidence
Studies (1)
  1. Carillon 2014 · Nutrients · RCT · n=61 — Dietary supplementation with a superoxide dismutase-melon concentrate reduces stress, physical and mental fatigue in healthy people: a randomised, double-blind, placebo-controlled trial

Mechanisms of action

Direct free radical trapping and chemical quenching

★★☆☆☆Mechanism evidence: grade DPrimary target

SOD catalyzes the dismutation of superoxide anion. This is an enzyme-catalyzed reaction, not direct quenching by a small molecule. However, it has not been confirmed whether a plant-derived enzyme taken by mouth can act directly in human tissues, and a rise in blood SOD activity cannot tell supplement-derived enzyme apart from the body’s own enzyme.

References (2)
  1. 2011 · Human randomized trial: blood SOD activity increased, but the study did not distinguish the supplemented plant enzyme from the body’s own enzyme
  2. Vouldoukis et al. 2004 · Animal study: the product changed antioxidant enzyme activity, but this cannot show that the intact exogenous enzyme acts directly in human tissue

Nrf2/ARE activation of endogenous antioxidant enzymes

★☆☆☆☆Mechanism evidence: grade DSecondary target

In a human trial in athletes, red blood cell SOD activity rose after supplementation, but Nrf2, NQO1 and HO-1 were not measured. Animal studies observed changes in antioxidant enzyme activity, but this cannot establish Nrf2/ARE activation in humans. A Peyer’s patch-mediated mechanism has not been confirmed either.

References (2)
  1. 2011 · Human randomized trial: red blood cell SOD activity rose in athletes after supplementation, but Nrf2, NQO1 and HO-1 were not measured
  2. Vouldoukis et al. 2004 · Animal study: changes in antioxidant enzyme activity were observed, but this does not establish Nrf2/ARE activation in humans

Mast cell membrane stabilization and degranulation blockade

★☆☆☆☆Mechanism evidence: grade DSecondary target

Research has observed that the product can reduce UV-induced solar erythema, but a change in erythema cannot show that mast cells were stabilized. There are also no reliable human studies that directly measure its effect on mast cell degranulation, histamine or tryptase after oral intake.

References (1)
  1. Literature search found no direct study · Conclusion: no reliable human study has directly measured mast cell degranulation, histamine or tryptase inhibition after oral GliSODin

Safety and drug interactions

Not suitable for people with celiac disease or wheat allergy, because the product uses a wheat protein carrier. It is contraindicated in severe celiac disease or severe wheat gluten allergy.
Open in the interactive app ›